(Q34416359)

2 August 2017

title

Evidence for polymorphic oxidation of sparteine in Japanese subjects (English)

1 reference

2 August 2017

Ishizaki T

1

1 reference

2 August 2017

Eichelbaum M

2

1 reference

2 August 2017

Horai Y

3

1 reference

2 August 2017

Hashimoto K

4

1 reference

2 August 2017

Chiba K

5

1 reference

2 August 2017

Dengler HJ

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 1987

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

23

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

482-485

1 reference

Sparteine metabolism in Canadian Caucasians

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386100

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386100

Polymorphic drug oxidation in humans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386100

The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386100

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386100

Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and Caucasians

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386100

Genetically determined variability in acetylation and oxidation. Therapeutic implications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386100

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386100

Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1987.TB03080.X

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1987.TB03080.X

Genetical and geographic studies on isoniazid inactivation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1987.TB03080.X

Deficient metabolism of debrisoquine and sparteine

21 January 2018

1 reference

12 December 2020

Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians

1 reference

12 December 2020

Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans

1 reference

12 December 2020

The genetic polymorphism of sparteine metabolism

1 reference

12 December 2020

10.1111/J.1365-2125.1987.TB03080.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference